Range Low Price High Price Comment
30 days $84.81 $100.98 Thursday, 28th Mar 2024 BPMC stock ended at $94.86. This is 0.0738% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 2.38% from a day low at $93.75 to a day high of $95.98.
90 days $72.25 $100.98
52 weeks $41.54 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
2024-03-28 $95.00 $95.98 $93.75 $94.86 602 986
2024-03-27 $90.08 $94.91 $89.12 $94.79 557 253
2024-03-26 $89.53 $92.55 $88.26 $89.67 530 439
2024-03-25 $87.59 $89.58 $86.76 $88.22 331 391
2024-03-22 $89.91 $91.06 $87.04 $87.04 291 809
2024-03-21 $89.13 $91.81 $89.13 $90.05 747 809
2024-03-20 $87.12 $89.53 $84.81 $88.26 1 267 902
2024-03-19 $86.08 $89.45 $84.90 $87.97 1 491 824
2024-03-18 $90.86 $91.67 $86.10 $86.82 996 760
2024-03-15 $87.28 $90.75 $86.58 $90.50 1 120 059
2024-03-14 $90.00 $90.82 $86.36 $87.71 522 631
2024-03-13 $90.43 $92.25 $89.40 $90.60 534 253
2024-03-12 $89.14 $90.44 $87.04 $89.70 475 826
2024-03-11 $92.12 $92.82 $88.69 $89.47 508 387
2024-03-08 $92.18 $94.72 $91.93 $92.30 664 450
2024-03-07 $90.37 $92.74 $89.73 $92.04 992 473
2024-03-06 $89.00 $91.75 $88.92 $90.38 785 257
2024-03-05 $89.41 $90.84 $88.55 $89.67 588 124
2024-03-04 $95.26 $95.69 $90.39 $90.80 623 411
2024-03-01 $93.81 $98.06 $93.73 $95.12 780 008
2024-02-29 $98.82 $98.82 $92.95 $93.52 656 386
2024-02-28 $98.15 $100.98 $95.27 $95.45 883 785
2024-02-27 $95.00 $99.87 $95.00 $99.79 1 499 560
2024-02-26 $89.89 $95.57 $89.37 $95.05 1 258 373
2024-02-23 $86.69 $91.19 $86.62 $89.49 881 190
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT